Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2023-02-22 Annual Report
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
21380029O1RSZIAVOR95-2022-12-31-nl.xhtml
Annual Report Classification · 100% confidence The document is explicitly titled 'Geïntegreerd jaarverslag 2022' (Integrated Annual Report 2022) for UCB Biopharma SRL. It contains comprehensive sections including management reports, governance statements, remuneration reports, consolidated financial statements, and auditor reports. This aligns perfectly with the definition of an Annual Report (10-K). FY 2022
2023-02-22 Dutch
21380029O1RSZIAVOR95-2022-12-31-nl.zip
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-02-22 Dutch
PR disposal 23.09.22 -ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Disposal of own shares" and details a transaction where the company disposed of UCB shares OTC following stock option exercises related to its Long-Term Incentive Program. This directly concerns the company's own shares being transacted. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is short and contains specific transaction details, confirming it is the primary filing content, not just an announcement of a report.
2022-09-23 English
PR disposal 23.09.22 - FR.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and explicitly states that the company (UCB SA) has alienated (sold/disposed of) its own shares following the exercise of options by personnel, as required by Belgian Royal Decree (Article 8:6). This action directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation plans (LTI). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. The document is short and is an official regulatory announcement ('Information réglementée').
2022-09-23 French
PR disposal 23.09.22 - NL.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details a transaction where UCB disposed of 200 of its own shares on September 16, 2022, as part of long-term incentive plans for employees. This directly corresponds to the definition of a company buying back or selling its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification. The document is short and appears to be a formal regulatory announcement ('Gereglementeerde informatie').
2022-09-23 Dutch
220909 - Disposals of own shares_ENG.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Disposal of own shares' and explicitly states that UCB SA/NV has delivered for free a total of 742 UCB shares OTC to personnel in accordance with LTI plans. This action—the delivery/disposal of own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document is a short, regulated information press release announcing this specific transaction, making the code POS the most accurate fit.
2022-09-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.